GSK relationship map
GSK
GSK plc
GSKGSK plc
CHRSCoherus OncologyINVAInnoviva
2°Corden Pharma CHENÔVE SASunlisted
2°Glaxounlisted
2°Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN)unlisted
LQDALiquidiaRGNXRegenxbio2°Nippon Shinyaku Co., Ltd. (Nippon Shinyaku)unlisted
2°Nippon Shinyakuunlisted
ZLABZai LabZNTLZentalis Pharmaceuticals2°Recurium IPunlisted
2°GSKunlisted
2°Dana‑Farber Cancer Instituteunlisted
Sells to →
2°Zydus LifeSciencesunlisted
2°Zydusunlisted
2°Adimabunlisted
2°Sagard Healthcare Royalty Partnersunlisted
2°DRI Healthcare Trustunlisted
2°Whitehead Institute for Biomedical Researchunlisted
2°Children's Medical Centerunlisted
2°One customerunnamed in filing
2°Customers that each individually contributed 10% or more of total revenueunlisted
2°Panda Expressunlisted
2°Dairy Queenunlisted
2°Corden Pharma CHENÔVE SASunlisted
2°Glaxounlisted
2°Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN)unlisted
2°Swedish Orphan Biovitrum ABunlisted
2°Otsuka Pharmaceuticalunlisted
2°Bardaunlisted
2°Meijiunlisted
2°Royalty Pharmaunlisted
2°Takedaunlisted
2°Asuragenunlisted
← Buys from
GSKGSK plc
2°Corden Pharma CHENÔVE SASunlisted
2°Glaxounlisted
2°Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN)unlisted
2°Nippon Shinyaku Co., Ltd. (Nippon Shinyaku)unlisted
2°Nippon Shinyakuunlisted
2°Recurium IPunlisted
2°GSKunlisted
2°Dana‑Farber Cancer Instituteunlisted
Sells to →
suppliercustomer2°second-degree (Extended)
sector groupThick line = filed share ·Moves · 10:23 ETSources